Taking off the 20% Skinbio stake approx 15m, leaves Opti value around 13m seems to be plenty of upside with a growing list of products & partners. Probably worth a gamble who knows!
Very unlikely to need a rights issue with 4.5m in cash as of 31/12/21 & quote ‘trading in the first few weeks of the year has started well ‘. Ref: 19/01/22 update It’s more likely not knowing when the company will become profitable that is affecting the SP
Yes that’s right 8/11 Was thinking more of updates on the various proposals & which ones might be on the ballot, hopefully proposals which fit nicely with Webis …
Possibly back to November travel testing as you say ,travel testing will be on & off with low or high testing requirements depending on the circumstances of various countries but the underlying need for testing at home or travel will remain for sometime yet I would think. The figures/update should give a clearer picture of the future…..